KDR and diabetes mellitus: As we demonstrated previously, diabetes increased the activity of the SH2 domain-containing phosphatase 1 (SHP-1) and its binding with the receptors tyrosine kinase (RTK) VEGFR-2 and PDGFR-β, reducing receptor activity and downstream signaling pathways associated with proangiogenic actions (7, 24).